Literature DB >> 22252296

Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells.

Hanhui Huang1, Wenrong Zhao, Dan Yang.   

Abstract

Dysregulated Skp2 function promotes cell proliferation, which is consistent with observations of Skp2 over-expression in many types of human cancers, including cervical carcinoma (CC). However, the molecular mechanisms underlying elevated Skp2 expression have not been fully explored. Interleukin-6 (IL-6) induced Stat3 activation is viewed as crucial for multiple tumor growth and metastasis. Here, we demonstrate that Skp2 is a direct transcriptional target of Stat3 in the human cervical carcinoma cells. Our data show that IL-6 administration or transfection of a constitutively activated Stat3 in HeLa cells activates Skp2 mRNA transcription. Using luciferase reporter and ChIP assays, we show that Stat3 binds to the promoter region of Skp2 and promotes its activity through recruiting P300. As a result of the increase of Skp2 expression, endogenous p27 protein levels are markedly decreased. Thus, our results suggest a previously unknown Stat3-Skp2 molecular network controlling cervical carcinoma development.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252296     DOI: 10.1016/j.bbrc.2012.01.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

2.  Endothelin-1 stimulates expression of cyclin D1 and S-phase kinase-associated protein 2 by activating the transcription factor STAT3 in cultured rat astrocytes.

Authors:  Yutaka Koyama; Satoshi Sumie; Yasutaka Nakano; Tomoya Nagao; Shiho Tokumaru; Shotaro Michinaga
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

3.  Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.

Authors:  Seyung S Chung; Jaydutt V Vadgama
Journal:  Anticancer Res       Date:  2015-01       Impact factor: 2.480

4.  Cell adhesion tunes inflammatory TPL2 kinase signal transduction.

Authors:  Maria Vougioukalaki; Konstantina Georgila; Emmanouil I Athanasiadis; Aristides G Eliopoulos
Journal:  Cell Mol Life Sci       Date:  2022-02-26       Impact factor: 9.261

Review 5.  Role of STAT3 in lung cancer.

Authors:  Pranabananda Dutta; Nafiseh Sabri; Jinghong Li; Willis X Li
Journal:  JAKSTAT       Date:  2015-01-20

6.  Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.

Authors:  K H Koo; H Kim; Y-K Bae; K Kim; B-K Park; C-H Lee; Y-N Kim
Journal:  Cell Death Dis       Date:  2013-06-27       Impact factor: 8.469

7.  Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells.

Authors:  Seyung S Chung; Clement Aroh; Jaydutt V Vadgama
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

8.  BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells.

Authors:  J-J Lee; J-S Lee; M N Cui; H H Yun; H Y Kim; S H Lee; J-H Lee
Journal:  Cell Death Dis       Date:  2014-11-20       Impact factor: 8.469

9.  Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer.

Authors:  Xin Li; Lajos Gera; Shumin Zhang; Yanhua Chen; Lei Lou; Lauren Marie Wilson; Zhong-Ru Xie; Giuseppe Sautto; Degang Liu; Alira Danaher; Kenza Mamouni; Yang Yang; Yuhong Du; Haian Fu; Omer Kucuk; Adeboye O Osunkoya; Jia Zhou; Daqing Wu
Journal:  Theranostics       Date:  2021-05-08       Impact factor: 11.556

10.  p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance.

Authors:  Lindi Chen; Deborah A Tweddle
Journal:  Front Oncol       Date:  2012-11-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.